Drug information for VEPESID

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL 100MG Discontinued   ETOPOSIDE Etoposide CORDEN PHARMA 19557
2007-07-06 Review
2002-11-05 Letter
1999-04-02 Review
CAPSULE; ORAL 50MG Discontinued   ETOPOSIDE Etoposide CORDEN PHARMA   "
INJECTABLE; INJECTION 20MG/ML Discontinued   ETOPOSIDE Etoposide CORDEN PHARMA 18768
2007-07-06 Review
2002-11-05 Letter
1999-04-02 Review

Drug Adverse Effects information for VEPESID

Role code Indications Reaction # Reports
PS BONE SARCOMA ACUTE RESPIRATORY DISTRESS SYNDROME 3
PS BONE SARCOMA ALOPECIA 3
PS BONE SARCOMA ANAEMIA 3
PS BONE SARCOMA CARDIAC FAILURE 3
PS BONE SARCOMA GRANULOCYTOPENIA 3
PS BONE SARCOMA HISTIOCYTOSIS HAEMATOPHAGIC 3
PS BONE SARCOMA LEUKOPENIA 3
PS BONE SARCOMA MUCOSAL INFLAMMATION 3
PS BONE SARCOMA MULTI-ORGAN FAILURE 3
PS BONE SARCOMA ODYNOPHAGIA 3
PS BONE SARCOMA RASH MACULAR 3
PS BONE SARCOMA THROMBOCYTOPENIA 3
PS BONE SARCOMA TOXOPLASMOSIS 3
PS NEOPLASM MALIGNANT EXTREMITY NECROSIS 2
PS NEOPLASM MALIGNANT RAYNAUD'S PHENOMENON 2
PS OVARIAN NEOPLASM CAESAREAN SECTION 3
PS OVARIAN NEOPLASM LIVE BIRTH 6
PS OVARIAN NEOPLASM MATERNAL EXPOSURE DURING PREGNANCY 3
PS OVARIAN NEOPLASM NEUTROPHIL COUNT DECREASED 3
PS OVARIAN NEOPLASM PREGNANCY 6
PS OVARIAN NEOPLASM PREMATURE DELIVERY 6
PS SMALL CELL LUNG CANCER LIMITED STAGE ANAPHYLACTIC SHOCK 1
PS TERATOMA CAESAREAN SECTION 3
PS TERATOMA LIVE BIRTH 3
PS TERATOMA MATERNAL EXPOSURE DURING PREGNANCY 3
PS TERATOMA NEUTROPHIL COUNT DECREASED 3
PS TERATOMA PREGNANCY 3
PS TERATOMA PREMATURE DELIVERY 3
SS BONE NEOPLASM MALIGNANT ABSCESS 6
SS BONE NEOPLASM MALIGNANT ACUTE RESPIRATORY DISTRESS SYNDROME 6
SS BONE NEOPLASM MALIGNANT ALOPECIA 6
SS BONE NEOPLASM MALIGNANT ANAEMIA 6
SS BONE NEOPLASM MALIGNANT CARDIAC FAILURE 6
SS BONE NEOPLASM MALIGNANT DIZZINESS 6
SS BONE NEOPLASM MALIGNANT GRANULOCYTOPENIA 6
SS BONE NEOPLASM MALIGNANT HISTIOCYTOSIS HAEMATOPHAGIC 6
SS BONE NEOPLASM MALIGNANT INFLAMMATION 6
SS BONE NEOPLASM MALIGNANT LEUKOPENIA 6
SS BONE NEOPLASM MALIGNANT MUCOSAL INFLAMMATION 6
SS BONE NEOPLASM MALIGNANT MULTI-ORGAN FAILURE 6
SS BONE NEOPLASM MALIGNANT ODYNOPHAGIA 6
SS BONE NEOPLASM MALIGNANT PYREXIA 6
SS BONE NEOPLASM MALIGNANT RASH 6
SS BONE NEOPLASM MALIGNANT THROMBOCYTOPENIA 6
SS BONE NEOPLASM MALIGNANT TOXOPLASMOSIS 6
SS CARTILAGE NEOPLASM ABSCESS 6
SS CARTILAGE NEOPLASM ACUTE RESPIRATORY DISTRESS SYNDROME 6
SS CARTILAGE NEOPLASM ALOPECIA 6
SS CARTILAGE NEOPLASM ANAEMIA 6
SS CARTILAGE NEOPLASM CARDIAC FAILURE 6
SS CARTILAGE NEOPLASM DIZZINESS 6
SS CARTILAGE NEOPLASM GRANULOCYTOPENIA 6
SS CARTILAGE NEOPLASM HISTIOCYTOSIS HAEMATOPHAGIC 6
SS CARTILAGE NEOPLASM INFLAMMATION 6
SS CARTILAGE NEOPLASM LEUKOPENIA 6
SS CARTILAGE NEOPLASM MUCOSAL INFLAMMATION 6
SS CARTILAGE NEOPLASM MULTI-ORGAN FAILURE 6
SS CARTILAGE NEOPLASM ODYNOPHAGIA 6
SS CARTILAGE NEOPLASM PYREXIA 6
SS CARTILAGE NEOPLASM RASH 6
SS CARTILAGE NEOPLASM THROMBOCYTOPENIA 6
SS CARTILAGE NEOPLASM TOXOPLASMOSIS 6
SS OVARIAN NEOPLASM CAESAREAN SECTION 3
SS OVARIAN NEOPLASM LIVE BIRTH 3
SS OVARIAN NEOPLASM MATERNAL EXPOSURE DURING PREGNANCY 3
SS OVARIAN NEOPLASM NEUTROPHIL COUNT DECREASED 3
SS OVARIAN NEOPLASM PREGNANCY 3
SS OVARIAN NEOPLASM PREMATURE DELIVERY 3
SS PRODUCT USED FOR UNKNOWN INDICATION TOXIC EPIDERMAL NECROLYSIS 3
SS TERATOMA CAESAREAN SECTION 3
SS TERATOMA LIVE BIRTH 3
SS TERATOMA MATERNAL EXPOSURE DURING PREGNANCY 3
SS TERATOMA NEUTROPHIL COUNT DECREASED 3
SS TERATOMA PREGNANCY 3
SS TERATOMA PREMATURE DELIVERY 3
C ANALGESIC INTERVENTION SUPPORTIVE THERAPY FEBRILE NEUTROPENIA 1
C ANALGESIC INTERVENTION SUPPORTIVE THERAPY HAEMOGLOBIN DECREASED 1
C ANALGESIC INTERVENTION SUPPORTIVE THERAPY LEUKOCYTOSIS 1
C ANALGESIC INTERVENTION SUPPORTIVE THERAPY NEUTROPHIL COUNT INCREASED 1
C ANALGESIC INTERVENTION SUPPORTIVE THERAPY THROMBOCYTOPENIA 1
C ANTIFUNGAL TREATMENT DRUG INTERACTION 1
C ANTIFUNGAL TREATMENT ILEUS PARALYTIC 1
C B-CELL LYMPHOMA DRUG INTERACTION 1
C B-CELL LYMPHOMA ILEUS PARALYTIC 1
C CHEMOTHERAPY DEATH 1
C CHEMOTHERAPY FEBRILE NEUTROPENIA 1
C CHEMOTHERAPY HAEMOGLOBIN DECREASED 2
C CHEMOTHERAPY LEUKOCYTOSIS 1
C CHEMOTHERAPY NEUTROPHIL COUNT INCREASED 2
C CHEMOTHERAPY THROMBOCYTOPENIA 1
C CHRONIC OBSTRUCTIVE PULMONARY DISEASE FEBRILE NEUTROPENIA 1
C CHRONIC OBSTRUCTIVE PULMONARY DISEASE HAEMOGLOBIN DECREASED 1
C CHRONIC OBSTRUCTIVE PULMONARY DISEASE LEUKOCYTOSIS 1
C CHRONIC OBSTRUCTIVE PULMONARY DISEASE NEUTROPHIL COUNT INCREASED 1
C CHRONIC OBSTRUCTIVE PULMONARY DISEASE THROMBOCYTOPENIA 1
C DIFFUSE LARGE B-CELL LYMPHOMA DRUG INTERACTION 3
C DIFFUSE LARGE B-CELL LYMPHOMA ILEUS PARALYTIC 3
C LYMPHOMA DRUG INTERACTION 1
C LYMPHOMA ILEUS PARALYTIC 1
C PRODUCT USED FOR UNKNOWN INDICATION DEATH 1
C PRODUCT USED FOR UNKNOWN INDICATION FEBRILE NEUTROPENIA 1
C PRODUCT USED FOR UNKNOWN INDICATION HAEMOGLOBIN DECREASED 2
C PRODUCT USED FOR UNKNOWN INDICATION LEUKOCYTOSIS 1
C PRODUCT USED FOR UNKNOWN INDICATION NEUTROPHIL COUNT INCREASED 2
C PRODUCT USED FOR UNKNOWN INDICATION THROMBOCYTOPENIA 1
C PROPHYLAXIS FEBRILE NEUTROPENIA 1
C PROPHYLAXIS HAEMOGLOBIN DECREASED 1
C PROPHYLAXIS LEUKOCYTOSIS 1
C PROPHYLAXIS NEUTROPHIL COUNT INCREASED 1
C PROPHYLAXIS THROMBOCYTOPENIA 1
C SMALL CELL LUNG CANCER STAGE UNSPECIFIED RENAL INFARCT 2
Ads by Google